Target intelligence / Profile preview

Corneal endothelium protection

Molecular classification
Other (cell layer; sometimes classified as "epithelial-like cells" or "specialized barrier tissue")
01

Overview

The corneal endothelium is a specialized monolayer of hexagonal cells lining the posterior cornea, maintaining tissue clarity by regulating stromal hydration through active ion transport ("pump-leak" mechanism). It is critical for vision and especially vulnerable during surgery, trauma, aging, and disease. Its poor regenerative ability means cell loss leads to progressive corneal edema and visual impairment; therapies focus on protection, minimizing apoptosis, and promoting repair through drugs like Rho kinase inhibitors, gene therapy, and surgical technique improvements[1][2][3][4][5][6][7][8].

Other names
corneal endothelial cellsCECsposterior corneal monolayer
02

Mechanism of action

Promotion of endothelial cell migration and repair (Rho kinase inhibitors); Anti-apoptotic action (Bcl-xL, p35); Mechanical protection from trauma during surgery (chopper shield technique)

03

Biological functions

Maintenance of corneal hydration and transparency through "pump-leak" (ion/fluid transport) mechanismsBarrier function (selective permeability)Cell migration and repair upon injuryApoptosis resistance mechanisms
04

Disease associations

Corneal endothelial decompensation (edema, bullous keratopathy)Vision loss secondary to cell dysfunctionGraft failure in corneal transplantation
05

Safety considerations

Limited regenerative capacity (cell loss is mostly compensated by migration, not proliferation)Graft rejection (immunologic risk after transplantation)Edema and vision loss due to therapy failureRisks associated with gene therapy (e.g., viral vector biodistribution)
06

Interacting drugs

Rho kinase inhibitors (e.g., Y-27632)

2 more in the full profile.

07

Biomarkers

Endothelial cell density (cells/mm²) measured by specular microscopy; loss below threshold predicts edemaCentral corneal thickness (swelling indicates dysfunction)

Beyond the preview

Go deeper on Corneal endothelium protection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal endothelium protection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call